Week 10 Diseases and vocab

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/57

encourage image

There's no tags or description

Looks like no tags are added yet.

58 Terms

1
New cards

causative agent -flu

influenza virus

2
New cards

causative agent- hepatitis a

hepatitis a virus

3
New cards

causative agent -hepatitis b

hepatitis b virus

4
New cards

classification- flu

8 segment ssRNA (-) gnome, enveloped virion 80-00nm, four types (A-D), hemagglutinin (HA) spikes, neuraminidase (NA) spikes, H1N1, H7N7.

5
New cards

classification- hepatitis a

Single-stranded ssRNA (+) genome of 7.48 kb, 3 different genotypes I, II, and III, spherican viron 27-30 nm, non-enveloped.

6
New cards

classification- hepatitis b

Single and double-stranded circular DNA, enveloped, spherical virion 42 nm, 4 protein coding genes

7
New cards

reservoir- flu

humans and other vertebrates

8
New cards

poe- flu

respiratory tract

9
New cards

mot- flu

direct, airborne/ droplet, contaminated surface contact

10
New cards

reservoir- hep a

humans

11
New cards

poe- hep a

digestive tract

12
New cards

mot- hep a

fecal-oral route, contaminated food or water, virus may be viable and infectious in environments for months

13
New cards

reservoir- hep b

humans and chimps

14
New cards

poe- hep b

compromised skin or mucosa

15
New cards

mot- hep b

direct via contaminated body fluids including blood and semen, vertical, sharing items with contaminated blood, viability or virus outside host is 7 days

16
New cards

incubation- flu

1-2 days

17
New cards

incubation- hep a

2-7 weeks

18
New cards

incubation- hep b

8-21 weeks

19
New cards

pathogenesis- flu

Hemagglutinin (HA) spikes facilitate attatchment and entry into ciliated epithelial cells. Viruses replicate and spread to other cells of lower respiratory tract including alveolar cells. Damage to mucociliary escalator results in secondary bacterial infections.

20
New cards

pathogenesis- hep a

Ingested virus infects liver. Virus replicates in liver cells and is eventually released into bile and eliminated in feces. Cellular damage and acute inflammations interfere with normal liver function.

21
New cards

pathogenesis- hep b

Virus enters the blood stream and travels to liver. Attaches to and enters liver cells via HBsAg. Immune cells attack infected liver cells causing cirrhosis. Integration of viral DNA into the host genome can lead to cancer.

22
New cards

symptoms- flu

Fever, cough, sore throat, runny/ stuffy nose, body aches, headache, chills, fatigue, somestimes diarrhea and vomiting, ussualy resolved in about week. More serious stymptoms include difficulty breathing, shortness of breath, pain or pressure in chest, dizziness, confusion, severe vomiting.

23
New cards

symptoms- hep a

Lasting 2-3 weeks: dark urine (bilirubinemia), jaundice (7% <5 yrs, 37% 5-9yrs, 70% adolescents and adults), clay colored feces, enlarged liver, mild flulike symptoms.

24
New cards

symptoms- hep b

Can persist for as long as 6 months, latency stage (months -years) asymptomatic, acute, fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay-colored stools, joint pain, jaundice.

25
New cards

complications- flu

Upper respiratory tract infections, ear infections, worsening of asthma or other chronic conditons, pneumonia, inflammation of other organs including heart, brain and kidneys, sepsis, death.

26
New cards

complications- hep a

Relapsing hepatitis, autoimmune hepatitis, loss of bile production (cholestatic hepatitis), rarely sever liver damage or failure (fulminant hepatitis).

27
New cards

complications- hep b

Chronic infection 10% (90% 0-1, 25-50% 1-5, 6-10% 10+) may be symptoms free or suffer from malaise, loss of appetite, general fatigue, liver cirrhosis, liver cancer, liver failure, mortality 15-25% of chronically infected.

28
New cards

treatment- flu

rest, fluids, supportive care, antiviral drugs, m2 inhibitors, neuraminidase inhibitors (Tamiflu)

29
New cards

treatment- hep a

rest, fluids, adequate nutrition

30
New cards

treatment- hep b

acute: rest fluids, adequate nutrition

chronic: antivirals, interferon

31
New cards

prevention- flu

Vaccination (egg-based cell or recombinant, mRNA (mFlusia), regular prevention of germ spread.

32
New cards

prevention- hep a

Vaccination, good hygiene practices, safe food handling procedures, effective sanitation.

33
New cards

prevention- hep b

Vaccination, practice universal precautions, avoid exposure to contaminated fluids,

34
New cards

causative organism- c jakob disease

Miss folded Prion Protein (PRP^SC)

35
New cards

classification- c jakob

Prion protein coded by PRNP gene, predisposing sequence mutations (Valine-12 + Glutamic acid-200 > lysine)

36
New cards

reservoir- c jakob

humans, mammals, environment

37
New cards

poe- c jakob

digestive tract or open wounds

38
New cards

mot- c jakob

ingestion of infected meat, contact with infected tisssue or environmentsal prion (<1% of cases) Non-contagoius acquisition: sporadic (85-94%) hereditary (10%), mean age onset 50-60 years.

39
New cards

incubation- c jakob

weeks to years

40
New cards

pathogenesis- c jakob

Miss folded prion proteins resist digestion and induce miss folding of normals (PRP) protiens. PRP^SC forms water insouluble aggregates that damage nerve cells and impair brain function.

41
New cards

symptoms- c jakob

Dementia, memory loss, hallucinations, paranoia, OCD, sleep disturbance, problem with muscle control.

42
New cards

complications- c jakob

Severe brain damage, secondary infections, mortality 85% within 2 years of symptom onset, median life expectancy about 4 months.

43
New cards

treatment- c jakob

no cure, palliative care

44
New cards

prevention- c jakob

Don't eat contaminated met, avoid blood or tissue transfusions from possible infected individuals, follow strict safety precautions, incinerate contaminated material.

45
New cards

gene

segment of dna that encodes a functional product, usually a protein

46
New cards

genome

all of the genetic material in a cell (or population)

47
New cards

genotype

dna sequence variant usually associated with a phenotype

48
New cards

phenotype

observable trait associated with expression of genes

49
New cards

nucleotide polymers

adenine, thymine, cytosine, guanine

50
New cards

backbone

sugar (deoxyribose)- phosphate

51
New cards

strands

held together by hydrogen bonds between AT and CG

52
New cards

polymerase

enzyme which replicates dna

53
New cards

gyrase- type II topoisomerase

uncoils dna and removes/prevents super coils

54
New cards

helicase

pulls dna apart

55
New cards

primase

adds rna primer

56
New cards

Okazaki fragments

pieces of new dna which are added to the lagging strand

57
New cards

ligase

seals the gap between the 3’ and 5’ ends of Okazaki fragments

58
New cards

quinolones and novobiocin

dna replication inhibitors